公开(公告)号：US20240299423A1

公开(公告)日：2024-09-12

申请号：US18574027

申请日：2022-07-06

申请人： Innocan Pharma Ltd.

发明人： Nir AVRAM

IPC分类号： A61K31/00 ,  A61K8/34 ,  A61K8/37 ,  A61K8/49 ,  A61K8/891 ,  A61K8/92 ,  A61K9/00 ,  A61K9/06 ,  A61K31/165 ,  A61K36/23 ,  A61K36/25 ,  A61K36/31 ,  A61Q19/00

CPC分类号： A61K31/658 ,  A61K8/342 ,  A61K8/345 ,  A61K8/375 ,  A61K8/4946 ,  A61K8/891 ,  A61K8/92 ,  A61K9/0019 ,  A61K9/06 ,  A61K31/165 ,  A61K36/23 ,  A61K36/25 ,  A61K36/31 ,  A61Q19/007

摘要： Described herein are compositions which can be used to improve circulation and thereby treat ailments of diabetic patients. The compositions comprise a cannabinoid, preferably cannabidiol. Further described herein are compositions comprising a cannabinoid, and a blood flow enhancing agent. Methods for treatment of diabetic patients are also disclosed.

公开(公告)号：US12065420B2

公开(公告)日：2024-08-20

申请号：US17270767

申请日：2019-08-28

申请人： HARDIE HEALTH LIMITED

发明人： Peter Thomas Northcote ,  Ameet Jonathan Singh

IPC分类号： A61K36/25 ,  A61P31/04 ,  C07D307/93 ,  C07D307/935

CPC分类号： C07D307/935 ,  A61K36/25 ,  C07D307/93 ,  A61K2236/333 ,  A61K2236/39 ,  A61P31/04

摘要： Disclosed herein are compositions containing an isolated bioactive compound of Formula (X):




including less than about 2 wt % of halifordin. Also disclosed are methods for obtaining and using compositions containing the isolated bioactive compound.

公开(公告)号：US20230190853A1

公开(公告)日：2023-06-22

申请号：US17996840

申请日：2021-04-20

申请人： MAX ZELLER SOEHNE AG

发明人： Georg BOONEN ,  Matthias-Heinrich KREUTER ,  Lucia DISCH

IPC分类号： A61K36/63 ,  A61K36/38 ,  A61K36/25

CPC分类号： A61K36/63 ,  A61K36/25 ,  A61K36/38 ,  A61K2236/39 ,  A61K2236/333

摘要： The present invention is directed to a method for preparing plant extracts comprising the steps of (i) preparing a soluble extract from (a) plants or parts thereof and (b) an aqueous, alcoholic or aqueous alcoholic mixed extractant; and removal of insoluble components, (ii) concentrating the extract to a dry substance content at which the contained lipids and lipoids form suspended and/or emulgated aggregates, (iii) separating the suspended and/or emulgated aggregates by microfiltration from the concentrated extract, and (iv) optionally removing the extractant. The invention further pertains to an extract and composition comprising said extract as prepared by this method.

公开(公告)号：US11364279B2

公开(公告)日：2022-06-21

申请号：US16073876

申请日：2017-01-20

申请人： Shandong Zhonghai Pharmaceutical CO. LTD

发明人： Long Cheng ,  Baozhen Xu ,  Qian Cheng

IPC分类号： A61K38/16 ,  A61K31/4025 ,  A61K35/62 ,  A61K36/02 ,  A61K36/03 ,  A61K36/04 ,  A61K36/05 ,  A61K36/25 ,  A61K36/284 ,  A61K31/7012 ,  A61P9/12 ,  A61K31/715

摘要： A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

公开(公告)号：US10967032B2

公开(公告)日：2021-04-06

申请号：US15992326

申请日：2018-05-30

申请人： Mun Fei Yam

发明人： Mun Fei Yam ,  Yean Chun Loh ,  Seng Hooi Loh

IPC分类号： A61K36/258 ,  A61K36/488 ,  A61K36/00 ,  A61K36/25 ,  A61K36/74 ,  A61K36/884 ,  A61P9/12

摘要： The present invention relates to a hypertension treatment. More particularly, the present invention relates to combination of four herbs' extract including 95% ethanolic extract of U. rhynchophylla (UR95), 95% ethanolic extract of P. thomsonii (PT95), 95% ethanolic extract of P. notoginseng (PN95), and 50% ethanolic extract of A. orientale (AO50) in particular range of ratio (known as F1 ratio), and all the raw herbs were then extracted in total by using 50% ethanol (known as F1-2) for use in a medicament for treating hypertension and hypertension-related complications and a composition thereof.

公开(公告)号：US10660924B2

公开(公告)日：2020-05-26

申请号：US15777891

申请日：2016-11-02

申请人： NATURAL RESPONSE, S.A.

发明人： Leandro Padilla Iglesias ,  Andres Valencia Michaud

IPC分类号： C07C13/62 ,  A61K36/185 ,  A61K36/73 ,  A61K36/25 ,  A61K36/896 ,  A61K36/48 ,  A61K36/77

摘要： The present application relates to a method for obtaining and purifying saponins from plant extracts, through a series of salting and filtrations steps, to provide high purity saponin extracts on large scale.

公开(公告)号：US20200093878A1

公开(公告)日：2020-03-26

申请号：US16142872

申请日：2018-09-26

申请人： Aretha Duncan

发明人： Aretha Duncan

IPC分类号： A61K36/296 ,  A61K36/41 ,  A61K36/25 ,  A61K36/185 ,  A61K36/81 ,  A61K36/31 ,  A61K36/88 ,  A61K36/48

摘要： A synergistic herbal stimulant composition comprises a mixture, in powdered or extract form, of two or more herbal stimulant ingredients and at least one catalytic herbal ingredient, which effects a synergy between the herbal stimulant ingredients. The herbal stimulant ingredients are preferably selected from the group consisting of Horny Goat Weed (Epimedium Sagittatum), Rhodiola Root (Rhodiola Rosea), Elueuthero Root (Eleutherococcus), Nettle Leaf (Urticaria Dioica), Ashwagandha Root (Withania Somnifera), Maca Root (Lepidium Meyenii), Moringa Root (Moringa Oleifera), and Cowitch (Macuna Pruriens). The catalytic herbal ingredient is preferably Moses-in-a-basket (Tradescantia Spathacea).

公开(公告)号：US20190038710A1

公开(公告)日：2019-02-07

申请号：US16073876

申请日：2017-01-20

申请人： Long CHENG

发明人： Long CHENG ,  Baozhen XU ,  Qian CHENG

IPC分类号： A61K38/16 ,  A61K31/715 ,  A61K31/7012 ,  A61K31/4025 ,  A61K36/05 ,  A61K36/04 ,  A61K36/02 ,  A61K36/03 ,  A61K36/25 ,  A61K35/62 ,  A61K36/284 ,  A61P9/12

摘要： A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

公开(公告)号：US09301989B2

公开(公告)日：2016-04-05

申请号：US14365582

申请日：2012-11-09

申请人： KOREA FOOD RESEARCH INSTITUTE

发明人： Mee Ra Rhyu ,  Hee Jin Son ,  Yi Seul Kim ,  Min Jung Kim ,  Hye Young Kim ,  Jae-Ho Park

IPC分类号： A01N65/00 ,  A61K36/8962 ,  A61K36/31 ,  A61K36/896 ,  A61K36/21 ,  A61K36/23 ,  A61K36/28 ,  A61K36/53 ,  A61K31/085 ,  A61K36/236 ,  A61K36/25 ,  A61K36/288 ,  A61K36/532 ,  A61K36/533 ,  G01N33/50

CPC分类号： A61K36/8962 ,  A61K31/085 ,  A61K36/21 ,  A61K36/23 ,  A61K36/236 ,  A61K36/25 ,  A61K36/28 ,  A61K36/288 ,  A61K36/31 ,  A61K36/53 ,  A61K36/532 ,  A61K36/533 ,  A61K36/896 ,  G01N33/5097 ,  G01N2500/04

摘要： A coniferyl alcohol or a Compositae family, Brassicaceae family, Umbelliferae family, Lamiaceae family, Liliaceae family or Amaranthaceae plant extract provides various uses associated with hTRPA1 activation, and, being a natural compound, involves relatively few side effects in the body and has substantial industrial applicability. The coniferyl alcohol or the Compositae family, Brassicaceae family, Umbelliferae family, Lamiaceae family, Liliaceae family or Amaranthaceae plant extract of the present invention not only will be a novel medical or food raw material which is helpful in maintaining homeostasis in the body associated with hTRPA1 activation, but can also be used to advantage in hTRPA1 antagonist screening.

摘要翻译： 扁桃体醇或菊科，芸苔科，伞形科，紫菜科，百合科或苋科植物提取物提供与hTRPA1活化相关的各种用途，作为天然化合物，在体内涉及相对较少的副作用， 适用性。 本发明的针叶树醇或菊科，菊科，伞形科，蔷薇科，百合科或苋属植物提取物不仅是有助于维持与hTRPA1相关的体内的体内平衡的新型医药或食品原料 激活，但也可用于hTRPA1拮抗剂筛选中的优势。

公开(公告)号：US20160015762A1

公开(公告)日：2016-01-21

申请号：US14333645

申请日：2014-07-17

申请人： Jonathan Shelley Nimitz

发明人： Jonathan Shelley Nimitz

IPC分类号： A61K36/25 ,  A61K33/30 ,  A61K36/19 ,  A61K36/481 ,  A61K45/06 ,  A61K36/23 ,  A61K36/539 ,  A61K31/716 ,  A61K36/63 ,  A61K36/185 ,  A61K36/315

CPC分类号： A61K45/06 ,  A61K31/716 ,  A61K33/30 ,  A61K36/185 ,  A61K36/254 ,  A61K2300/00

摘要： The present invention relates to the field of dietary supplements, and in particular to antiviral compositions and methods of use. Compositions are described involving various combinations of Andrographis, Astragalus, Eleuthero, Isatis, Lomatium, Pelargonium, Sambucus, Scute, and/or Zinc, optionally with additional components. These combinations of supplements synergistically reduce both severity and duration of viral infections, including in particular colds and influenza, as well as providing additional benefits.

摘要翻译： 本发明涉及膳食补充剂领域，特别涉及抗病毒组合物和使用方法。 描述了包括穿心莲，黄芪，埃柳塞罗，茜素，茉莉，天竺葵，接骨木蛋白，Scute和/或锌的各种组合的组合物，任选地含有另外的组分。 这些补充剂的组合协同地减少病毒感染的严重性和持续时间，特别是感冒和流感，以及提供额外的益处。